Launxp Biomedical Co

Launxp Biomedical Co EBIT per Share

The EBIT per Share of Launxp Biomedical Co (6876.TWO) as of Oct 11, 2026 is -2.54 TWD. In the previous year, EBIT per Share was -1.77 TWD — a change of 43.49% (lower).

EBIT per Share

-2.54TWD

YoY

43.49%

Last updated:

EBIT per Share of Launxp Biomedical Co is 2024 -2.54 TWD. EBIT per Share of Launxp Biomedical Co was 2023 -1.77 TWD. It decreases by 43.49% lower compared to the previous year.

The Launxp Biomedical Co EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2020
-0.89 TWD
Jan 1, 2021
-0.76 TWD
Jan 1, 2022
-0.95 TWD
Jan 1, 2023
-1.77 TWD
Jan 1, 2024
-2.54 TWD
The Launxp Biomedical Co EBIT per Share history
YEAREBIT per ShareYoY
-2.54TWD+43.49%
-1.77TWD+85.81%
-0.95TWD+25.24%
-0.76TWD-14.93%
-0.89TWD—
Access this data via the Eulerpool API
Get Free API Key

Launxp Biomedical Co Stock analysis

What does Launxp Biomedical Co do? Launxp Biomedical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Launxp Biomedical Co stock

EBIT per Share of Launxp Biomedical Co is -2.54 TWD in 2024.

EBIT per Share of Launxp Biomedical Co changed from -1.77 TWD to -2.54 TWD, representing a 43.49% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Launxp Biomedical Co since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Launxp Biomedical Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Launxp Biomedical Co